President Donald Trump's imposition of tariffs on Canada, Mexico and China has sparked trade-war tensions amid a mix of reprieves and retaliations. But as the Trump tariffs rattle Wall Street, the IBD Breakout Stocks Index showcases a slew of breakout moves from the likes of Axon Enterprise, Meta Platforms, CrowdStrike and more.
As Axon looks to launch a new breakout move and Meta stock keeps notching record highs, note that both companies made the latest list of new buys by the best mutual funds, which comes out on Friday. Showing their strength as top growth stocks, Meta earns a spot on the IBD Big Cap 20, while CrowdStrike secures placement on that screen and the IBD 50. Axon also makes both, plus it has a spot on IBD Sector Leaders, our most stringent screen.
Trump Tariffs, TikTok Ban Are Sideshows In Possible U.S.-China Deal Of The Century
Breakout Brigade Sets Up — With One Trade
Updated weekly, the IBD Breakout Stocks Index highlights stocks that recently launched new climbs or are on the verge of doing so. By mirroring the names on the index, the Innovator IBD Breakout Opportunities exchange traded fund allows investors to own a piece of each index member with a single trade.
The BOUT ETF continues to build a handle as part of an early-stage cup-with-handle formation. The buy point is 41.63.
Currently trading 2% shy of that entry, the ETF popped back above the 50-day moving average on Wednesday.
See Who Joins Axon and Meta On The IBD Breakout Stocks Index
Meta Stock, Axon, CrowdStrike, Samsara Lead Charge
Several members of the IBD Breakout Stocks Index — such as Meta, Atlassian and Hims & Hers Health — have already climbed beyond buy range. But led by Axon and Samsara, a barrage of stocks in or near buy range has also emerged. Up nearly 3% Wednesday, CrowdStrike is now extended out of buy range.
Axon has crafted a second-stage cup pattern with a 698.67 buy point. Samsara has built a similar base showing a 57.51 entry.
Other names also stand ready to break out, including Docusign and Doximity, just to name a few.
MakeMyTrip, MercadoLibre and GitLab also fit that bill.
HubSpot, featured in the IBD Stock Analysis on Jan. 17, has moved back into buy range from a 762.47 entry it first cleared last month.
IBD 50 member Duolingo broke out on Tuesday and now trades near the top of its buy range.
IBD Breakout Opportunities ETF
The IBD Breakout Opportunities ETF from Innovator Capital Management tracks the IBD Breakout Stocks Index. As with other index ETFs, this fund allows you to invest in the entire index in addition to, or rather than, buying individual stocks. Learn more here about the ETF and Innovator.
Follow Matthew Galgani on X (formerly Twitter) at @IBD_MGalgani.
